Results
eNauka >
Results >
Clinical comparison of the biosimilar ABP 980 and trastuzumab in early breast cancer: Results of the phase 3 LILAC study and justification for extrapolation across approved trastuzumab indications
| Title: | Clinical comparison of the biosimilar ABP 980 and trastuzumab in early breast cancer: Results of the phase 3 LILAC study and justification for extrapolation across approved trastuzumab indications | Authors: | Kolberg, Hans-Christian; Tomasevic, Zoran M; Demetriou, Georgia S; von, Minckwitz Gunter; Fujiwara, Yasuhiro; Ponomarova, O; Tesch, Hans; Santi, Patricia Xavier; Hanes, Vladimir | Issue Date: | 2018 | Publication: | EUROPEAN JOURNAL OF CANCER | ISSN: | 0959-8049 European Journal of Cancer / EJC Search Idenfier |
Type: | Conference Paper | Collation: | vol. 92 str. S103-S104 | WoS-ID: | 000429103100279 | URI: | https://enauka.gov.rs/handle/123456789/818498 | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
2
WEB OF SCIENCETM
Google ScholarTM
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.